MX156114A - Procedimiento para la obtencion de derivados de piridina - Google Patents

Procedimiento para la obtencion de derivados de piridina

Info

Publication number
MX156114A
MX156114A MX191934A MX19193482A MX156114A MX 156114 A MX156114 A MX 156114A MX 191934 A MX191934 A MX 191934A MX 19193482 A MX19193482 A MX 19193482A MX 156114 A MX156114 A MX 156114A
Authority
MX
Mexico
Prior art keywords
procedure
obtaining
piridine derivatives
piridine
derivatives
Prior art date
Application number
MX191934A
Other languages
English (en)
Spanish (es)
Inventor
Manoury Philippe
Binet Jean
Cavero Icilio
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of MX156114A publication Critical patent/MX156114A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX191934A 1981-03-25 1982-03-23 Procedimiento para la obtencion de derivados de piridina MX156114A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8106005A FR2502618A1 (fr) 1981-03-25 1981-03-25 Derives de pyridine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
MX156114A true MX156114A (es) 1988-07-12

Family

ID=9256643

Family Applications (1)

Application Number Title Priority Date Filing Date
MX191934A MX156114A (es) 1981-03-25 1982-03-23 Procedimiento para la obtencion de derivados de piridina

Country Status (20)

Country Link
US (1) US4406907A (enExample)
EP (1) EP0061379B1 (enExample)
JP (1) JPS57169462A (enExample)
AR (1) AR231281A1 (enExample)
AT (1) ATE15895T1 (enExample)
AU (1) AU545747B2 (enExample)
CA (1) CA1185978A (enExample)
DE (1) DE3266607D1 (enExample)
DK (1) DK156652C (enExample)
ES (1) ES8303346A1 (enExample)
FI (1) FI75808C (enExample)
FR (1) FR2502618A1 (enExample)
GR (1) GR75930B (enExample)
HU (1) HU186488B (enExample)
IE (1) IE52654B1 (enExample)
IL (1) IL65336A (enExample)
MX (1) MX156114A (enExample)
NO (1) NO159850C (enExample)
NZ (1) NZ200118A (enExample)
ZA (1) ZA822008B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6218598A (en) * 1997-01-30 1998-08-25 Synthelabo Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
CN113490670B (zh) 2019-08-05 2023-06-02 北京志健金瑞生物医药科技有限公司 含氮多环稠环类化合物,其药物组合物、制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano

Also Published As

Publication number Publication date
ES510724A0 (es) 1983-02-01
AU8187382A (en) 1982-09-30
IL65336A (en) 1985-08-30
IE820682L (en) 1982-09-25
JPS57169462A (en) 1982-10-19
FI821034A0 (fi) 1982-03-24
FR2502618A1 (fr) 1982-10-01
HU186488B (en) 1985-08-28
EP0061379A1 (fr) 1982-09-29
AU545747B2 (en) 1985-08-01
ZA822008B (en) 1983-02-23
DK156652C (da) 1990-02-05
US4406907A (en) 1983-09-27
FI821034L (fi) 1982-09-26
DK133282A (da) 1982-09-26
FR2502618B1 (enExample) 1983-12-23
IE52654B1 (en) 1988-01-06
CA1185978A (en) 1985-04-23
NO159850B (no) 1988-11-07
FI75808C (fi) 1988-08-08
FI75808B (fi) 1988-04-29
NO159850C (no) 1989-02-15
NZ200118A (en) 1984-09-28
NO820979L (no) 1982-09-27
ES8303346A1 (es) 1983-02-01
AR231281A1 (es) 1984-10-31
ATE15895T1 (de) 1985-10-15
GR75930B (enExample) 1984-08-02
IL65336A0 (en) 1982-05-31
EP0061379B1 (fr) 1985-10-02
JPS6135185B2 (enExample) 1986-08-12
DE3266607D1 (en) 1985-11-07
DK156652B (da) 1989-09-18

Similar Documents

Publication Publication Date Title
ES555048A0 (es) Procedimiento para la obtencion de derivados de azolilmetil-ciclopropilcarbinol sustituido
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
MX156153A (es) Procedimiento para producir derivados de carboestirilo
ES544162A0 (es) Procedimiento para preparar derivados de heparina
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
ES556156A0 (es) Procedimiento para la obtencion de derivados de la 13-beta-milbemicina
ES510685A0 (es) Procedimiento para la obtencion de derivados de quinolinona.
ES512295A0 (es) Procedimiento para preparar derivados de piridina.
ES516717A0 (es) Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio.
ES504256A0 (es) Procedimiento para la obtencion de derivados de triazolil- propenol
ES542946A0 (es) Procedimiento para la obtencion de derivados piperazinicos
ES527515A0 (es) Procedimiento para la obtencion de benzofuranonas
ES525298A0 (es) Procedimiento para preparar derivados de quinolina
ES543991A0 (es) Procedimiento para la obtencion de derivados de indol
MX7583E (es) Procedimiento para la obtencion de derivados de piperazina
ES508803A0 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES526892A0 (es) Procedimiento para la obtencion de benzofuranonas
ES542421A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- quinolina-1-ilcarbonilimidazol.
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES511911A0 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES527054A0 (es) Procedimiento para la obtencion de derivados bis-quinazolinicos
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
AR231281A1 (es) Procedimiento para preparar derivados de piridina
ES510955A0 (es) Procedimiento para la obtencion de metilomelaminas monomeras
ES547487A0 (es) Procedimiento para la obtencion de derivados de la pirazolo-na